Search results
Apellis (APLS) Up More Than 60% in Past 3 Months: Here's Why
Zacks via Yahoo News· 2 years agoApellis' (APLS) marketed drug, Empaveli, approved for treating paroxysmal nocturnal hemoglobinuria...
Apellis' (APLS) Q3 Earnings Miss Estimates, Revenues Top Mark
Zacks via Yahoo News· 2 years agoApellis Pharmaceuticals, Inc. APLS reported a loss per share of $1.75 for third-quarter 2022, wider...
4 Large Drug Stocks to Watch in a Booming Industry
Zacks via Yahoo News· 2 years agoDrug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, Johnson & Johnson (JNJ),...
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Zacks via Yahoo News· 2 months agoAstraZeneca AZN announced its long-term plan to generate $80 billion in total revenues by 2030,...
Apellis (APLS) Rises on FDA Acceptance of NDA Amendment for GA
Zacks via Yahoo News· 2 years agoThe FDA accepts Apellis' (APLS) major amendment to the NDA for pegcetacoplan to treat geographic...
Top Analyst Reports for BHP Group, AstraZeneca & Boeing
Zacks via Yahoo News· 1 year agoToday's Research Daily features new research reports on 16 major stocks, including BHP Group Limited...
Top Research Reports for Chevron, AstraZeneca & Netflix
Zacks via Yahoo News· 10 months agoToday's Research Daily features new research reports on 16 major stocks, including Chevron...
Top Research Reports for Exxon Mobil, Coca-Cola & AstraZeneca
Zacks via Yahoo News· 1 year agoToday's Research Daily features new research reports on 16 major stocks, including Exxon Mobil...
Pharma Stock Roundup: J&J's $8.9B Offer for Talc Litigation Settlement & Other Updates
Zacks via Yahoo News· 1 year agoJ&J (JNJ) offers a $8.9 billion settlement to resolve its talc lawsuits. FDA approves Merck's (MRK)...
Top Analyst Reports for Mastercard, AstraZeneca & Philip Morris
Zacks via Yahoo News· 1 year agoToday's Research Daily features new research reports on 16 major stocks, including Mastercard...